15.00-17.00

Satellite symposium: Management of PNH in the Soliris@ (eculizumab) era - Nordic Perspective. Preregistration
needed. More info: christopher.briele@physicians-world.eu
Chairman: Prof. Magnus Björkholm, Stockholm. Speaker: Dr Anita Hills, Leeds.

17.30-20.15

Satellite symposium CLL in the spotlight (+buffet) - see separate program sent out by GSK. Preregistration needed.
More info: elisabeth.l.birkdal@gsk.com
Chair person: Assoc. prof. Eva Kimby. Speakers: Prof. Richard Rosenquist-Brandell and
prof. Anders Österborg.

08.00-19.00

Registration

08.30-10.30

Nordic ALL-meeting - "strategies and results from the ALL2008 protocol"
All interested hematologists are welcome!

K3

09.00-13.00

Nordic Bone Marrow Transplantation group meeting (NBMT)
More info: jonas.mattsson@ki.se

K2

11.15-13.00

Symposium: Population-based registries in hematology – what have we learned and how should we proceed?
Chair person Prof. Magnus Björkholm, Stockholm. Prof. Peter de Nully Brown, Copenhagen, prof. Gunnar Juliusson, Lund, assoc. prof. Jon-Magnus Tangen, Oslo, assoc. prof, Helsinki, assoc. prof. Bertil Lindahl, Uppsala (Uppsala Clinical Research Centre; registries in cardiology).

Hall B

13.00-14.00

Lunch

14.00-14.05

Welcome

14.05-15.30

Increasing role of allo-SCT in malignant lymphomas and CLL. Assoc. prof. Hans Hägglund, Stockholm (chair), Assoc. prof.Arne Kolstad, University Hospital, Oslo

Hall B

15.30-16.00

Coffee & Exhibition

16.00-17.55

Myeloproliferative diseases. Chair person Prof. Gunnar Birgegård, Uppsala

Hall B

16.00-16.45

JAK2 mutations - implications for the pathogenesis and treatment of polycythemia vera.
Assoc. Prof. Jan Samuelsson, Stockholm

Hall B

16.45-17.00

Musical interlude

Hall B

17.00-17.55

Myeloproliferative diseases – issues in modern management of ET and MF, Assoc. prof. Mats Merup, London

Hall B

18.00

Welcome reception at UKK

Floor 6

19.00-20.30

Satellite symposium: Defining new standards in indolent NHL and CLL (+ buffet). Preregistration not required.
Chair person: Hans Hagberg. Speakers: Hans Hagberg and Eva Kimby

Floor 3 -Hall B

08.15-10.00

CLL. Chair person Prof. Eva Kimby, Stockholm

Hall B

08.15-09.05

Chronic lymphocytic leukaemia: Prognostic factors and patogenesis. Prof. Richard Rosenqvist-Brandell, Uppsala

Hall B

09.10-10.00

CLL- controversies: Role of antibodies in first and second line treatment?
Pro: prof. Christian Geissler, Copenhagen. Contra: prof. Eva Kimby, Stockholm

Hall B

10.00-10.30

Coffee & Exhibition

10.30-11.30

Acute lymphoblastic leukaemia: Paradigm shift and new concepts in treating ”younger” patients. Prof. Kjell Schmiegelow, Denmark

Hall B

11.30-12.30

Symposium: How to inform patients in the transition to palliative care. Chair person Gunnar Birgegård. Dr Anna Milberg, Norrköping

Hall B

12.30-13.30

Lunch

13.30-15.15

Thromboembolism and cancer. Chair person MD PhD Gerd Lärfars, Stockholm

Hall B

13.30-14.15

Thromboembolic complications in cancer patients. Assoc. Prof Margareta Holmström, Stockholm

Hall B

14.15-15.15

New drugs in preventing and treating thrombosis.
Prof. Sam Schulman, Hamilton, Canada (by video-link)

Hall B

15.15-15.45

Coffee & Exhibition

15.45-17.30

Multiple myeloma – state of the art and controversies. ChAssoc. Prof Martin Hjorth, Lidköping (chair). Prof. Peter Gimsing, Copenhagen

Hall B

17.30-18.00

Annual meeting Nordic Society of Hematology.

Hall B

19.00

Conference dinner at Östgöta nation with entertainment, including renowned speaker
Hans Rosling, Prof of International Health, Stockholm, ”Is the state of the world
what we beleive it to be”?

08.30-10.00

Acute myeloid leukaemia. Chair person: Prof. Eva Hellström-Lindberg, Stockholm

Hall B

08.30-09.20

Genetic diagnostics in acute leukaemia - now and future. Prof. Claudia Haferlach, Munich

Hall B

09.20-10.00

New drugs in the treatment of AML.
Prof. Björn Tore Gjertsen, Bergen

Hall B

10.00-10.30

Coffee & Exhibition

10.30-12.00

Debate: Better for the patient, more expensive for the clinic = increasing dilemma for the doctor: How to evaluate the cost-effectiveness of the novel haematologic drugs. Chair person Prof. Jan Westin, Göteborg.
Prof. Jörgen Schiöler Kristensen, Århus, Prof. Jan Lilliemark Swedish MPA/SBU, General Director Richard Bergström (LIF, pharmaceutical industry), PhD Fredrik Nilsson (Health Economist), Dental and Pharmaceutical Benefits Agency ("TLV"),
Assoc. prof Ulf Hallgårde, Region Skåne

Hall B

12.00-13.00

Lunch

13.00-14.50

Clinical frontlines in ITP and CML. Chair persons: assoc. prof. Martin Höglund, Uppsala and prof. Johan Richter, Lund

Hall B

13.00-14.00

TKIs in very-good-responder-CML – stop or non-stop? Prof Kimmo Porkka, Helsinki

Hall B

14.00-14.50

Autoimmune thrombocytopenia – choice of second line treatment and role of TPO-agonists. Prof. Hans Wadenvik, Göteborg

Hall B

14.50

Closing words

08.00-19.00

Registration

10.00-11.00

Annual meeting of HEMSIS (Swedish Hematology Nurses Society)

Hall C

11.15-13.00

see - main program!

Hall B

13.00-14.00

Lunch

14.00-14.05

Welcome

Hall C

14.05-15.30

Stem cell transplantation and sexuality Chair person: nurse Ann-Carin Svanberg

Hall C

14.05-14.50

Gynelogical complications after stem cell transplantation.
Dr. Eva Smith Knutsson, Trollhättan

Hall C

14.50-15.30

The impact of SCT on sexual life
Nurse Christel Wendt, Lund, Nurse Sölvi Vejby, Uppsala (information to the patient pre/post SCT)

Hall C

15.30-16.00

Coffee & Exhibition

16.00-17.45

Nurse – patient relation Chair person: nurse Ann-Carin Svanberg

Hall C

16.00-16.50

Ethical problems, attitudes
PhD Anna Höglund, Uppsala

Hall C

17.00-17.45

”The Insider and Outsider Perspective – clinical importance of agreement between patients and nurses in cancer care” PhD Gunilla Mårtensson, Uppsala

Hall C

18.00

Welcome reception at UKK

Floor 6

08.15-09.15

To talk to patients about difficult issues.
Prof. Gunnar Birgegård, Uppsala

Hall C

09.15-11.30

Management of infections in immunodeficient patients. Chair person Ann-Carin Svanberg

Hall C

09.15-10.15

Multiresistant bacteria – an emerging problem in hematological patients, Dr Birgitta Lytsy, Uppsala

Hall C

10.15-10.45

Coffee & Exhibition

10.45-11.30

Antibiotic treatment of patients with febrile neutropenia Dr Honar Cherif, Uppsala

Hall C

11.30-12.30

Symposium: How to inform patients in the transition to palliative care.
Chair person Gunnar Birgegård, MD PhD Anna Milberg, PhD, Norrköping

Hall B

12.30-13.30

Lunch

13.30-17.30

Nurses are very welcome to participate in the general sessions on Thursday afternoon and on Friday 23/4

Hall B

19.00

Conference dinner at Östgöta nation with entertainment, including renowned speaker
Hans Rosling, prof of International Health, Stockholm (”Is the state of the world what we beleive it to be”?)